Skip to primary navigation Skip to main content

Buyer Beware: The Danger of Purchasing Pharmaceuticals over the Internet - Day 2
Federal and Private Sector Responses

Permanent Subcommittee on Investigations

Location: Room 342, Dirksen Senate Office Building

Watch this video with Real Player
Open in New Window

Agenda

The Permanent Subcommittee on Investigations had is second day of hearings on the danger of purchasing pharmaceuticals over the Internet on July 22, 2004.  The Subcommittee held its first hearing on this issue on June 17, 2004. 

The Subcommittee hearings examined the extent to which consumers can purchase pharmaceuticals over the Internet without a medical prescription, the importation of pharmaceuticals into the United States, and whether the pharmaceuticals from foreign sources are counterfeit, expired, unsafe, or illegitimate. In addition, the Subcommittee hearings examined the extent to which U.S. consumers can purchase dangerous and often addictive controlled substances from Internet pharmacy websites and the procedures utilized by the Bureau of Customs and Border Protection, the Drug Enforcement Administration, the United States Postal Service, and the Food and Drug Administration, as well as the private sector to address these issues.

Witnesses

Panel 1

  • Mr.  Richard M. Stana
    Director, Homeland Security and Justice Team
    General Accounting Office
    Washington, D.C.
    Download Testimony (1026k)

Panel 2

  • The Honorable  Karen P. Tandy
    Administrator
    Drug Enforcement Administration
    Washington, DC
    Download Testimony (50 KB)
  • Mr.  Lee R. Heath
    Chief Postal Inspector
    United States Postal Service
    Washington, DC
    Download Testimony (79 KB)
  • Mr.  Jayson P. Ahern
    Assistant Commissioner, Office of Field Operationsdows N
    Bureau of Customs & Border Protection
    Washington, D.C.
    Download Testimony (84.5 KB)
  • Mr.  John M. Taylor
    Associate Commissioner for Regulatory Affairs
    Food and Drug Administration
    Rockville, Maryland
    Download Testimony (1829k)
  • Mr.  William Hubbard
    Associate Commissioner for Policy and Planning
    Food and Drug Administration
    Rockville, Maryland

Panel 3